Zhaoke Ophthalmology Announces First Interim Results

NTC010 Approved by The Hainan Provincial Medical Products Administration for the Import as an Urgently Needed Drug

Podcast Series Episode 2: Dry Eye Disease prevalence in China and Zhaoke’s potential treatment solution

Zhaoke Ophthalmology’s IND Application for Phase III Clinical Trial of NVK-002 for Myopia Treatment in China Accepted for Review by CDE

Zhaoke Ophthalmology’s Last Patient Completed Treatment for Phase III Clinical Trial of Cyclosporine A (CsA) Ophthalmic Gel for Dry Eye Disease, New Drug Application Planned Around the End of 2021